Sponsor content
112 result(s) found, displaying 91 to 100
-
Cancellation by sponsorRequested by Cipla Australia Pty Ltd
-
Cancellation by sponsorRequested by Cipla Australia Pty Ltd
-
Prescription medicine registrationActive ingredients: icatibant acetate.
-
Prescription medicine registrationActive ingredients: medroxyprogesterone acetate.
-
Prescription medicine registrationActive ingredients: gefitinib.
-
Prescription medicine registrationActive ingredients: pregabalin.
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020